-
1
-
-
0141468244
-
Kidney disease as a risk factor for development of cardiovascular disease
-
M.J. Sarnak, A.S. Levey, A.C. Schoolwerth, J. Coresh, B. Culleton, L.L. Hamm, P.A. McCullough, B.L. Kasiske, E. Kelepouris, M.J. Klag, P. Parfrey, M. Pfeffer, L. Raij, D.J. Spinosa, P.W. Wilson Kidney disease as a risk factor for development of cardiovascular disease Circulation 108 2003 2154 2169
-
(2003)
Circulation
, vol.108
, pp. 2154-2169
-
-
Sarnak, M.J.1
Levey, A.S.2
Schoolwerth, A.C.3
Coresh, J.4
Culleton, B.5
Hamm, L.L.6
McCullough, P.A.7
Kasiske, B.L.8
Kelepouris, E.9
Klag, M.J.10
Parfrey, P.11
Pfeffer, M.12
Raij, L.13
Spinosa, D.J.14
Wilson, P.W.15
-
2
-
-
72449208198
-
Hyperkalemia in patients with heart failure: Incidence, prevalence, and management
-
A. Desai Hyperkalemia in patients with heart failure: incidence, prevalence, and management Curr Heart Fail Rep 6 2009 272 280
-
(2009)
Curr Heart Fail Rep
, vol.6
, pp. 272-280
-
-
Desai, A.1
-
3
-
-
0018831590
-
Hyperkalemia and hyporeninemic hypoaldosteronism
-
R.A. DeFronzo Hyperkalemia and hyporeninemic hypoaldosteronism Kidney Int 17 1980 118 134
-
(1980)
Kidney Int
, vol.17
, pp. 118-134
-
-
Defronzo, R.A.1
-
4
-
-
67649470527
-
The frequency of hyperkalemia and its significance in chronic kidney disease
-
L.M. Einhorn, M. Zhan, V.D. Hsu, L.D. Walker, M.F. Moen, S.L. Seliger, M.R. Weir, J.C. Fink The frequency of hyperkalemia and its significance in chronic kidney disease Arch Intern Med 169 2009 1156 1162
-
(2009)
Arch Intern Med
, vol.169
, pp. 1156-1162
-
-
Einhorn, L.M.1
Zhan, M.2
Hsu, V.D.3
Walker, L.D.4
Moen, M.F.5
Seliger, S.L.6
Weir, M.R.7
Fink, J.C.8
-
5
-
-
64149098797
-
Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients
-
B. Wozakowska-Kapon, I. Janowska-Molenda Iatrogenic hyperkalemia as a serious problem in therapy of cardiovascular diseases in elderly patients Pol Arch Med Wewn 119 2009 141 147
-
(2009)
Pol Arch Med Wewn
, vol.119
, pp. 141-147
-
-
Wozakowska-Kapon, B.1
Janowska-Molenda, I.2
-
6
-
-
0033735928
-
ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failure
-
G.L. Bakris, M. Siomos, D. Richardson, I. Janssen, W.K. Bolton, L. Hebert, R. Agarwal, D. Catanzaro ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure Kidney Int 58 2000 2084 2092
-
(2000)
Kidney Int
, vol.58
, pp. 2084-2092
-
-
Bakris, G.L.1
Siomos, M.2
Richardson, D.3
Janssen, I.4
Bolton, W.K.5
Hebert, L.6
Agarwal, R.7
Catanzaro, D.8
-
7
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure
-
B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 1999 709 717
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes, J.8
-
8
-
-
3442886513
-
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
-
D.N. Juurlink, M.M. Mamdani, D.S. Lee, A. Kopp, P.C. Austin, A. Laupacis, D.A. Redelmeier Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study N Engl J Med 351 2004 543 551
-
(2004)
N Engl J Med
, vol.351
, pp. 543-551
-
-
Juurlink, D.N.1
Mamdani, M.M.2
Lee, D.S.3
Kopp, A.4
Austin, P.C.5
Laupacis, A.6
Redelmeier, D.A.7
-
9
-
-
1642502319
-
National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
A.S. Levey, J. Coresh, E. Balk, A.T. Kausz, A. Levin, M.W. Steffes, R.J. Hogg, R.D. Perrone, J. Lau, G. Eknoyan National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification Ann Intern Med 139 2003 137 147
-
(2003)
Ann Intern Med
, vol.139
, pp. 137-147
-
-
Levey, A.S.1
Coresh, J.2
Balk, E.3
Kausz, A.T.4
Levin, A.5
Steffes, M.W.6
Hogg, R.J.7
Perrone, R.D.8
Lau, J.9
Eknoyan, G.10
-
10
-
-
67651115710
-
Sudden death and associated factors in a historical cohort of chronic haemodialysis patients
-
S. Genovesi, M.G. Valsecchi, E. Rossi, D. Pogliani, I. Acquistapace, V. De Cristofaro, A. Stella, A. Vincenti Sudden death and associated factors in a historical cohort of chronic haemodialysis patients Nephrol Dial Transplant 24 2009 2529 2536
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 2529-2536
-
-
Genovesi, S.1
Valsecchi, M.G.2
Rossi, E.3
Pogliani, D.4
Acquistapace, I.5
De Cristofaro, V.6
Stella, A.7
Vincenti, A.8
-
11
-
-
31644438457
-
Cardiovascular risk factors in chronic kidney disease
-
V. Menon, A. Gul, M.J. Sarnak Cardiovascular risk factors in chronic kidney disease Kidney Int 68 2005 1413 1418
-
(2005)
Kidney Int
, vol.68
, pp. 1413-1418
-
-
Menon, V.1
Gul, A.2
Sarnak, M.J.3
-
12
-
-
33748713630
-
Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: A retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials
-
S. de Denus, J.-C. Tardif, M. White, M.G. Bourassa, N. Racine, S. Levesque, A. Ducharme Quantification of the risk and predictors of hyperkalemia in patients with left ventricular dysfunction: a retrospective analysis of the Studies of Left Ventricular Dysfunction (SOLVD) trials Am Heart J 152 2006 705 712
-
(2006)
Am Heart J
, vol.152
, pp. 705-712
-
-
De Denus, S.1
Tardif, J.-C.2
White, M.3
Bourassa, M.G.4
Racine, N.5
Levesque, S.6
Ducharme, A.7
-
13
-
-
41149101190
-
Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: A systematic review and meta-analysis of randomized controlled trials
-
R. Lakhdar, M.H. Al-Mallah, D.E. Lanfear Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials J Card Fail 14 2008 181 188
-
(2008)
J Card Fail
, vol.14
, pp. 181-188
-
-
Lakhdar, R.1
Al-Mallah, M.H.2
Lanfear, D.E.3
-
14
-
-
35348976721
-
Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: A quantitative review of data from randomized clinical trials
-
C.O. Phillips, A. Kashani, D.K. Ko, G. Francis, H.M. Krumholz Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials Arch Intern Med 167 2007 1930 1936
-
(2007)
Arch Intern Med
, vol.167
, pp. 1930-1936
-
-
Phillips, C.O.1
Kashani, A.2
Ko, D.K.3
Francis, G.4
Krumholz, H.M.5
-
15
-
-
0035901585
-
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial
-
J.F.E. Mann, H.C. Gerstein, J. Pogue, J. Bosch, S. Yusuf Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 2001 629 636
-
(2001)
Ann Intern Med
, vol.134
, pp. 629-636
-
-
Mann, J.F.E.1
Gerstein, H.C.2
Pogue, J.3
Bosch, J.4
Yusuf, S.5
-
16
-
-
1042264337
-
What is the optimal serum potassium level in cardiovascular patients?
-
J.E. Macdonald, A.D. Struthers What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 43 2004 155 161
-
(2004)
J Am Coll Cardiol
, vol.43
, pp. 155-161
-
-
MacDonald, J.E.1
Struthers, A.D.2
-
17
-
-
55949112567
-
Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS)
-
B. Pitt, G. Bakris, L.M. Ruilope, L. DiCarlo, R. Mukherjee Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Circulation 118 2008 1643 1650
-
(2008)
Circulation
, vol.118
, pp. 1643-1650
-
-
Pitt, B.1
Bakris, G.2
Ruilope, L.M.3
Dicarlo, L.4
Mukherjee, R.5
-
18
-
-
35748951306
-
Incidence and predictors of hyperkalemia in patients with heart failure: An analysis of the CHARM program
-
A.S. Desai, K. Swedberg, J.J.V. McMurray, C.B. Granger, S. Yusuf, J.B. Young, M.E. Dunlap, S.D. Solomon, J.W. Hainer, B. Olofsson, E.L. Michelson, M.A. Pfeffer Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM program J Am Coll Cardiol 50 2007 1959 1966
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1959-1966
-
-
Desai, A.S.1
Swedberg, K.2
McMurray, J.J.V.3
Granger, C.B.4
Yusuf, S.5
Young, J.B.6
Dunlap, M.E.7
Solomon, S.D.8
Hainer, J.W.9
Olofsson, B.10
Michelson, E.L.11
Pfeffer, M.A.12
-
19
-
-
21244497660
-
The mineralocorticoid receptor and oxidative stress
-
A. Fiebeler, F.C. Luft The mineralocorticoid receptor and oxidative stress Heart Fail Rev 10 2005 47 52
-
(2005)
Heart Fail Rev
, vol.10
, pp. 47-52
-
-
Fiebeler, A.1
Luft, F.C.2
-
20
-
-
0642306163
-
Aldosteronism and peripheral blood mononuclear cell activation
-
R.A. Ahokas, K.J. Warrington, I.C. Gerling, Y. Sun, L.A. Wodi, P.A. Herring, L. Lu, S.K. Bhattacharya, A.E. Postlethwaite, K.T. Weber Aldosteronism and peripheral blood mononuclear cell activation Circ Res 93 2003 e124 e135
-
(2003)
Circ Res
, vol.93
-
-
Ahokas, R.A.1
Warrington, K.J.2
Gerling, I.C.3
Sun, Y.4
Wodi, L.A.5
Herring, P.A.6
Lu, L.7
Bhattacharya, S.K.8
Postlethwaite, A.E.9
Weber, K.T.10
|